Table 1. HIV Infections Averted (2014–2028) in Scenarios Scaling Up VMMC among Indicated Age Groups.
Age Group | Total HIA, Thousands | UI for Total HIA | Percentage of HIA among Males and Females, 15–49 | Male HIA, Thousands | UI for Male HIA | Female HIA, Thousands | UI for Female HIA |
---|---|---|---|---|---|---|---|
15–49 (current strategy) | 370 | (341, 400) | 100% | 248 | (228, 268) | 122 | (112, 132) |
10–49 | 377 | (351, 403) | 102% | 252 | (235, 270) | 124 | (116, 133) |
15–24 | 183 | (173, 192) | 49% | 122 | (116, 129) | 60 | (57, 63) |
15–29 | 245 | (232, 259) | 66% | 164 | (155, 174) | 81 | (77, 85) |
15–34 | 303 | (283, 323) | 82% | 203 | (190, 217) | 100 | (93, 107) |
10–24 | 189 | (180, 198) | 51% | 127 | (120, 133) | 62 | (59, 65) |
10–29 | 253 | (239, 267) | 68% | 169 | (160, 179) | 83 | (79, 88) |
10–34 | 310 | (290, 330) | 84% | 207 | (194, 221) | 102 | (96, 109) |
HIA: HIV infections averted. UI: uncertainty interval. Each row represents scale-up of VMMC among the indicated age group, compared with a reference case in which male circumcision prevalence is maintained at base levels from before the initiation of the VMMC program. Percentage of HIA compares the HIA achieved by scale-up of VMMC in the indicated age group with the HIA achieved by scaling up among ages 15–49, the current strategy at the time the analysis was conducted. Uncertainty intervals are described in [11].